Version 5.4
Bos taurus Protein: BT.44261
Summary
InnateDB Protein IDBP-690733.2
Last Modified 2014-10-13 [Report errors or provide feedback]
Gene Symbol BT.44261
Protein Name tumor necrosis factor ligand superfamily member 8
Synonyms TNFRSF8;
Species Bos taurus
Ensembl Protein ENSBTAP00000036314
InnateDB Gene IDBG-638653 (BT.44261)
Protein Structure
UniProt Annotation
Function
Subcellular Localization
Disease Associations
Tissue Specificity
Comments
Interactions
Number of Interactions This gene and/or its encoded proteins are associated with 0 experimentally validated interaction(s) in this database.
They are also associated with 1 interaction(s) predicted by orthology.
Predicted by orthology
Total 1 [view]
Gene Ontology

Molecular Function
Accession GO Term
GO:0005125 cytokine activity
GO:0005164 tumor necrosis factor receptor binding
GO:0005515 protein binding
Biological Process
GO:0006955 immune response
GO:0043374 CD8-positive, alpha-beta T cell differentiation
GO:0045944 positive regulation of transcription from RNA polymerase II promoter
GO:0050830 defense response to Gram-positive bacterium
Cellular Component
GO:0005615 extracellular space
GO:0016020 membrane
Protein Structure and Domains
PDB ID
InterPro IPR006052 Tumour necrosis factor domain
IPR008983 Tumour necrosis factor-like domain
PFAM PF00229
PRINTS
PIRSF
SMART SM00207
TIGRFAMs
Post-translational Modifications
Modification
Cross-References
SwissProt
PhosphoSite PhosphoSite-
TrEMBL F1MGQ7
UniProt Splice Variant
Entrez Gene 574056
UniGene Bt.44261
RefSeq NP_001020378
HUGO
OMIM
CCDS
HPRD
IMGT
EMBL DAAA02024589
GenPept

If you use InnateDB for your research, please cite the following publication:

Breuer et al., InnateDB: systems biology of innate immunity and beyond - recent updates and continuing curation. Nucl. Acids Res. (2013) 41 (D1) 

InnateDB is being developed jointly by the Brinkman Laboratory (Simon Fraser University, British Columbia, Canada), the Hancock Laboratory (University of British Columbia, Vancouver, British Columbia) and the Lynn EMBL Australia Group (South Australian Health & Medical Research Institute and Flinders University, Adelaide, Australia).

Funding is currently provided by Allergen and EMBL Australia. Previous funding has been provided by Genome Canada, the Foundation for the National Institutes of Health through the Grand Challenges in Global Health initiative and by Teagasc. InnateDB curated interactions are licensed under the Design Science License. All other data is licensed under the terms of the originating database. Contact: innatedb-mail@sfu.ca